NTAGI’s Covid working group to review SII’s Covovax data for use in 12 year olds and above
Covid working group of NTAGI will review this week data of Serum Institute of India’s (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19 vaccination programme for inoculating those aged 12 years and above, official sources said on Wednesday. India’s drug regulator had approved Covovax for restricted use in … Read more